INDUSTRY INSIGHTS YOUR PEERS ARE READING
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset MORE
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them. MORE
American saw the greatest number of deaths from suicide and alcohol- and drug-induced fatalities was recorded in 2016. That statistic of nearly 142,000 equates to deaths from stroke and exceed the number of deaths among Americans who died in all U.S. MORE
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S. MORE
Health Consumers Health costs Medicines Patient engagement Personal health finance Pharmaceutical Pharmacy Popular culture and health MORE
National health spending in the U.S. is expected to grow by 5.7% MORE
“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”. MORE
Patients are the new healthcare payors, and as such, taking on the role of health consumers. In fact, health and wellness consumers have existed since a person purchased the first toothpaste, aspirin, heating pad, and moisturizing cream at retail. MORE
Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center. MORE
Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes. MORE
What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four? MORE
Topical Antibiotic Pharmaceuticals Market: Drivers and Restraints. Global topical antibiotic pharmaceuticals is projected to grow rapidly due to increasing prevalence of skin and soft tissue infections as well as increasing availability and affordability of topical antibiotic products. Major drivers for the topical antibiotic pharmaceuticals market are increasing combination of drugs with different chemical moieties for treating various skin infections. MORE
is “regressive” and ultimately hurting patients, pharmaceutical executives said Tuesday at a Senate hearing. The current structure of reimbursement for drugs in the U.S. MORE
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People MORE
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter. MORE
135 
Lee Carter, president of language strategy firm Maslansky + Partners, works with hospitals, pharmaceutical companies and insurance companies grappling with healthcare pricing MORE
The report pointed especially to hospital and pharmaceutical prices. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure. MORE
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter. MORE
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs MORE
Today is Boxing Day and St. Stephens Day for people who celebrate Christmas, so I share this post as a holiday gift with well-wishes for you and those you love. MORE
Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception MORE
All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers. MORE
But electronic prescribing alone doesn’t solve the Holy Grail challenge for both the pharmaceutical industry and providers: medication adherence. MORE
Jianke.com, China's online healthcare platform, yesterday announced during the Jianke Doctor Rebrand & 2018 Jianke Partners' Conference in Shanghai that they will be entering into a strategic partnership with US-based global pharmaceutical leader Pfizer MORE
115 
Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found. MORE
Cancer Financial health Financial wellness Global Health Health costs Health finance Health policy Medical innovation Medicines Money and health Pharmaceutical Pharmacy Prescription drugs Specialty drugs Sustainability MORE
consumers have long-ranked the pharmaceutical industry relatively low, but above car salespeople and the Federal government. The prices of medicines prescribed in outpatient settings rose, on average. 10.3% in 2018. MORE
” These ratings cover over 2,100 pharmaceutical brands for which over 40,000 having submitted opinions. While the use of medicines continues to rise in the U.S., spending grew by only 0.6% in 2017 after accounting for discounts and rebates. MORE
EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives. MORE
[link]. Becker’s Healthcare is pleased to release the “150 Top Places to Work in Healthcare | 2018” list, which highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, employee engagement and professional growth. MORE
During the hearing, Senator Patty Murray (D-WA) challenged Azar, “As a pharmaceutical executive, you raised drug prices year after year. CVS Health’s acquisition of Aetna was approved this week by U.S. MORE
The future of healthcare is not about being sick, Prof. Dr. Koen Kas believes. MORE
When it comes to healthcare costs, lines that decline over time are generally seen as good news. That’s how media outlets will cover the top-line of PwC’s report Medical cost trend: Behind the numbers 2019. However, there are other forces underneath the stable-looking 6.0% MORE
Democrats have been committed to the concept of the government negotiating drug prices directly with pharmaceutical companies the way other developed countries do. As Tip O’Neill’s mantra goes, “All politics is local.” ” In the U.S. MORE
ACA Affordable Care Act Bio/life sciences Biotech Financial health Financial wellness Health Consumers Health costs Health disparities Health Economics Health finance Health law Health policy Health politics Health reform Medical innovation Medicines Money and health Pharmaceutical Trust MORE
had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs). MORE
Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S. MORE
Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement. MORE
Mango Health will offer a custom white-label version of its app for high-risk patients taking specialty pharmaceuticals MORE
133 
In the U.S., trust in the healthcare industry declined by 9 percentage points in just one year, declining from 62% of people trusting — that’s roughly two-thirds of Americans — down to 53% — closer to one-half of the population. MORE
Most Americans have been surprised by a medical bill, a NORC AmeriSpeak survey found. Who’s responsible? Nearly all Americans (86% net responsible) first blame health insurance companies, followed by hospitals (82%). Fewer U.S. MORE
Pharmaceuticals Related Topics Electronic Health Reporter
AUGUST 28, 2018
The article How Pharmaceutical Companies Can Take Advantage of the EHR Revolution appeared first on electronichealthreporter.com. Editorial electronic health records formularies are standardized PharmaceuticalThis content is copyrighted strictly for Electronic Health Reporter.
Lloyd Price
NOVEMBER 26, 2018
In the latest episode of our podcast, Exchanges at Goldman Sachs, Stephanie Hui, head of Goldman Sachs' Merchant Banking Division in Asia-Pacific ex-Japan, explains how these dynamics are creating key investment opportunities in the pharmaceuticals, medical equipment and medical services markets. "People
Healthcare Guys
JANUARY 30, 2019
Topical Antibiotic Pharmaceuticals Market: Drivers and Restraints. Global topical antibiotic pharmaceuticals is projected to grow rapidly due to increasing prevalence of skin and soft tissue infections as well as increasing availability and affordability of topical antibiotic products. Major drivers for the topical antibiotic pharmaceuticals market are increasing combination of drugs with different chemical moieties for treating various skin infections.
Health Populi
FEBRUARY 21, 2019
National health spending in the U.S. is expected to grow by 5.7%
Health Populi
MARCH 6, 2019
That would be profits made by pharmaceutical companies, cited by 80% of respondents. Ironic that in this Congressional session, pharmaceutical manufacturers are testifying about the life-saving benefits of their products, but priced to drive about one-third of Americans not to adopt them.
Health Populi
JANUARY 29, 2019
Health Consumers Health costs Health law Health policy Health politics Pharmaceutical Pharmacy Prescription drugs
|
Electronic Health Reporter
OCTOBER 25, 2018
By Georgia Mitsi, PhD, MBA, senior director and head of digital healthcare initiatives, Sunovion Pharmaceuticals Inc. Editorial Georgia Mitsi improving patient care Sunovion PharmaceuticalsThis content is copyrighted strictly for Electronic Health Reporter.
Health Populi
FEBRUARY 10, 2019
But electronic prescribing alone doesn’t solve the Holy Grail challenge for both the pharmaceutical industry and providers: medication adherence.
FierceHealthIT
JUNE 22, 2018
After watching Martin Shkreli raise the price of a drug by more than 550% in 2015, Intermountain's Dan Liljenquist had the same thought as the rest of America: Is this really happening? So the system decided to create a nonprofit generic drug company that Liljenquist calls a “first-of-its-kind societal asset
Health Populi
AUGUST 7, 2018
One of the most concerning rising cost components in medical trend come from the pharmaceutical supply chain. The vast majority of employers do not believe the current rebate-based system works to reduce pharmaceutical costs, and most welcoming an alternative to rebates. More U.S.
Health Populi
AUGUST 6, 2018
All sectors who are stakeholders in the healthcare ecosystem aren’t created equal, Accenture explains in their report, Healthcare’s future winners and losers.
|
|
Health Populi
AUGUST 8, 2018
Health Consumers Health costs Medicines Patient engagement Personal health finance Pharmaceutical Pharmacy Popular culture and health
Health Populi
MAY 22, 2018
What could $28,166 buy you in 2018? A new car? A year of your child’s college education? A plot of land for your retirement home? Or a year of healthcare for a family of four?
Health Populi
JUNE 28, 2018
EpiPen pricing mainstreamed the issue of pharmaceutical costs as a democratized (small “d”) issue in 2016, when Mylan grew the cost of a two-pack to about $600. There are countless chasms in the U.S. this moment in social, political, and economic perspectives.
Health Populi
SEPTEMBER 16, 2018
Consumers who have long purchased over-the-counter medicines, anti-dandruff shampoo, whitening toothpaste, and cosmetics-with-benefits at food, drug and mass merchant retailers are switching to other places to shop for health, new data from AT Kearney and GMDC have found.
Health Populi
MARCH 15, 2018
had the highest pharmaceutical spending per capita of $1,443 versus $749 for the other nations, roughly double. The U.S. spent nearly twice as much as other wealthy countries on healthcare, mostly due to higher prices for both labor and products (especially prescription drugs).
Health Populi
JUNE 7, 2018
Financial health Health Consumers Health costs Health Economics Health policy Heart health Medicare Medicines Mental health Money and health Obesity Personal health finance Pharmaceutical Prescription drugs Prevention Public health Specialty drugs TransparencyThe U.S.
Health Populi
MAY 29, 2018
“Do no harm” has been the professional and ethical mantra of physicians since the Hippocratic Oath was first uttered by medical students. The origins of that three-word objective probably came out of Hippocrates’ Corpus , which included a few additional words: “to do good or to do no harm.”.
Health Populi
JUNE 5, 2018
Less can lead to more for so many things: eating smaller portions, lowering sugar consumption, and driving less in favor of walking or cycling come to mind. When it comes to healthcare utilization, doing less can also result in equal or even better outcomes.
Health Populi
MARCH 13, 2018
The report pointed especially to hospital and pharmaceutical prices. President Trump made clear on the campaign trail and in his interview with TIME magazine as Person of the Year that pharmaceutical companies’ pricing needed to be reined in using government pressure.
Health Populi
OCTOBER 12, 2018
During the hearing, Senator Patty Murray (D-WA) challenged Azar, “As a pharmaceutical executive, you raised drug prices year after year. CVS Health’s acquisition of Aetna was approved this week by U.S.
Health Populi
MAY 24, 2018
Cancer Financial health Financial wellness Global Health Health costs Health finance Health policy Medical innovation Medicines Money and health Pharmaceutical Pharmacy Prescription drugs Specialty drugs Sustainability
Health Populi
SEPTEMBER 14, 2018
Patients are the new healthcare payors, and as such, taking on the role of health consumers. In fact, health and wellness consumers have existed since a person purchased the first toothpaste, aspirin, heating pad, and moisturizing cream at retail.
Health Populi
SEPTEMBER 19, 2018
consumers have long-ranked the pharmaceutical industry relatively low, but above car salespeople and the Federal government. The prices of medicines prescribed in outpatient settings rose, on average. 10.3% in 2018.
Health Populi
APRIL 24, 2018
In the U.S., trust in the healthcare industry declined by 9 percentage points in just one year, declining from 62% of people trusting — that’s roughly two-thirds of Americans — down to 53% — closer to one-half of the population.
Health Populi
OCTOBER 17, 2018
The future of healthcare is not about being sick, Prof. Dr. Koen Kas believes.
Health Populi
MAY 17, 2018
American saw the greatest number of deaths from suicide and alcohol- and drug-induced fatalities was recorded in 2016. That statistic of nearly 142,000 equates to deaths from stroke and exceed the number of deaths among Americans who died in all U.S.
Health Populi
JUNE 13, 2018
When it comes to healthcare costs, lines that decline over time are generally seen as good news. That’s how media outlets will cover the top-line of PwC’s report Medical cost trend: Behind the numbers 2019. However, there are other forces underneath the stable-looking 6.0%
Health Populi
JULY 2, 2018
Most Americans say that pharmaceutical manufacturers, banks, advertisers, energy firms, and tech companies have too much power and influence in today’s American economy, according to Public Attitudes Toward Technology Companies , a research report from the Pew Research Center.
Health Populi
SEPTEMBER 4, 2018
Most Americans have been surprised by a medical bill, a NORC AmeriSpeak survey found. Who’s responsible? Nearly all Americans (86% net responsible) first blame health insurance companies, followed by hospitals (82%). Fewer U.S.
Health Populi
JULY 10, 2018
ACA Affordable Care Act Bio/life sciences Biotech Financial health Financial wellness Health Consumers Health costs Health disparities Health Economics Health finance Health law Health policy Health politics Health reform Medical innovation Medicines Money and health Pharmaceutical Trust
Health Populi
MAY 14, 2018
Smart Pharmaceuticals Index (NQSSPH) from May 11, 2018, the date when POTUS and Secretary Azar made their announcement.
Health Populi
APRIL 23, 2018
” These ratings cover over 2,100 pharmaceutical brands for which over 40,000 having submitted opinions. While the use of medicines continues to rise in the U.S., spending grew by only 0.6% in 2017 after accounting for discounts and rebates.
Health Populi
NOVEMBER 7, 2018
Democrats have been committed to the concept of the government negotiating drug prices directly with pharmaceutical companies the way other developed countries do. As Tip O’Neill’s mantra goes, “All politics is local.” ” In the U.S.
Mobi Health News
MARCH 5, 2019
Mango Health will offer a custom white-label version of its app for high-risk patients taking specialty pharmaceuticals
Mobi Health News
JUNE 8, 2018
Digital technologies are cementing their place across healthcare, and the pharmaceutical sector is no exception
FierceHealthIT
MARCH 12, 2019
Lee Carter, president of language strategy firm Maslansky + Partners, works with hospitals, pharmaceutical companies and insurance companies grappling with healthcare pricing
FierceHealthIT
FEBRUARY 26, 2019
is “regressive” and ultimately hurting patients, pharmaceutical executives said Tuesday at a Senate hearing. The current structure of reimbursement for drugs in the U.S.
Mobi Health News
NOVEMBER 29, 2018
Jianke.com, China's online healthcare platform, yesterday announced during the Jianke Doctor Rebrand & 2018 Jianke Partners' Conference in Shanghai that they will be entering into a strategic partnership with US-based global pharmaceutical leader Pfizer
Henry Kotula
JULY 15, 2018
[link]. Becker’s Healthcare is pleased to release the “150 Top Places to Work in Healthcare | 2018” list, which highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, employee engagement and professional growth.
Let's personalize your content